![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 31/17 | |
A61K 31/27 | |||
C07C 271/08 | |||
C07C 275/18 | |||
A61P 43/00 |
(11) | Number of the document | 2857015 |
(13) | Kind of document | T |
(96) | European patent application number | 14182803.8 |
Date of filing the European patent application | 2009-03-17 | |
(97) | Date of publication of the European application | 2015-04-08 |
(45) | Date of publication and mention of the grant of the patent | 2021-05-05 |
(46) | Date of publication of the claims translation |
(30) | Number | Date | Country code |
69857 P | 2008-03-18 | US | |
123621 P | 2008-04-09 | US | |
207220 P | 2009-02-09 | US | |
209453 P | 2009-03-06 | US |
(72) |
Tran, Thuy-Anh, US
Chen, Weichao, US
Kramer, Bryan A., US
Sadeque, Abu J. M., US
Shyfryna, Hanna L., US
Shin, Young-Jun, US
Vallar, Pureza, US
Zou, Ning, US
|
(73) |
Arena Pharmaceuticals, Inc.,
6154 Nancy Ridge Drive, San Diego, CA 92121,
US
|
(54) | Modulators of the prostacyclin (PG12) receptor useful for the treatment of disorders related thereto |
Modulators of the prostacyclin (PG12) receptor useful for the treatment of disorders related thereto |